StockWatch
·

STERLITE TECHNOLOGIES LTD. Q4 FY26 Results

STLTECHQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue1.4K14.6%37.0%
Total Income1.5K15.6%36.4%
Expenditure1.4K9.0%29.4%
PBT109.00619.0%5350.0%
Net Profit59.00447.1%247.5%
OPM15.68%7.33pp3.80pp
NPM4.03%5.37pp7.76pp
EPS1.21245.7%1110.0%
View full financials

STL FY26 Revenue ₹4,745 Cr; Board approves ₹2000 Cr fundraise

29 Apr 2026 · 29 Apr, 1:53 pm

Summary

Sterlite Technologies Limited announced resilient performance for FY26, with Q4FY26 revenues at INR 1,441 Cr, growing ~14.7% sequentially. For the full fiscal year, the company's revenues reached INR 4,745 Cr, up by ~18.8% year-on-year, with EBITDA at INR 628 Cr and margins of ~13.2%. STL demonstrated consistent sequential improvement in EBITDA margins for the sixth consecutive quarter, driven by higher utilization and an improved product mix. The year was marked by a transformative ~110% surge in order intake over FY25, bolstering the open order book to INR 7,309 Cr and providing strong revenue visibility for sustained growth. The emerging AI Data Centre business is highlighted as a key growth engine for the company.

Key Highlights

  1. 1

    Sterlite Technologies Limited reported Q4FY26 revenue of INR 1,441 Cr, reflecting a ~14.7% sequential growth.

  2. 2

    For the full financial year 2026, the company achieved revenues of INR 4,745 Cr, representing an ~18.8% year-on-year increase.

  3. 3

    STL's EBITDA for FY26 stood at INR 628 Cr, with EBITDA margins reaching approximately 13.2%.

  4. 4

    The company recorded a substantial ~110% surge in order intake over FY25, indicating strong future revenue visibility.

  5. 5

    The open order book at the end of FY26 was robust at INR 7,309 Cr, driven by major data-centre and telecom projects.

  6. 6

    The Board of Directors has not recommended any dividend for the financial year ended March 31, 2026.

  7. 7

    The Board approved a fundraising initiative of up to Rs. 2000 crores through various instruments, subject to necessary approvals.

Informational and educational content only. Not investment advice.